Patent details

EP1993673 Title: INJECTABLE COMBINATION THERAPY FOR EYE DISORDERS

Basic Information

Publication number:
EP1993673
PCT Application Number:
US2007001649
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077181121
PCT Publication Number:
WO2007084765
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INJECTABLE COMBINATION THERAPY FOR EYE DISORDERS
French Title of Invention:
TRAITEMENT COMBINATOIRE INJECTABLE DESTINE A DES TROUBLES OPHTALMIQUES
German Title of Invention:
INJIZIERBARE KOMBINATIONSTHERAPIE FÜR AUGENERKRANKUNGEN
SPC Number:

Dates

Filing date:
19/01/2007
Grant date:
28/06/2017
EP Publication Date:
26/11/2008
PCT Publication Date:
26/07/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/06/2017
EP B1 Publication Date:
28/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/01/2021
Expiration date:
19/01/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/11/2017
 
 

Name:
Apellis Pharmaceuticals, Inc.
Address:
6400 Westwind Way Suite A, Crestwood, KY 40014, United States (US)

History of Owners

From:
11/10/2017
To:
17/11/2017

Name:
Apellis Pharmaceuticals, Inc.
Address:
6400 Westwind Way Suite A, Crestwood, KY 40014, United States (US)

From:
28/06/2017
To:
11/10/2017

Name:
Potentia Pharmaceuticals, Inc.
Address:
201 East Jefferson Street, Suite 311, Louisville KY 40202, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
27/09/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
OLSON, Paul
Address:
United States (US)

2

Name:
FRANCOIS, Cedric
Address:
United States (US)

3

Name:
DESCHATELETS, Pascal
Address:
United States (US)

Priority

1

Priority Number:
760974 P
Priority Date:
19/01/2006
Priority Country:
United States (US)

2

Priority Number:
544389
Priority Date:
06/10/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61F 9/00; A61K 9/00; A61K 31/00; A61K 38/00; A61K 38/08; A61K 38/10; A61K 38/12; A61K 38/17; A61K 39/00; A61K 39/395; A61K 47/06; A61K 49/00; A61P 27/02;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2017/07
Publication date:
11/12/2017
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201726
Publication date:
28/06/2017
Description:
Grant (B1)

2

Issue number:
201751
Publication date:
20/12/2017
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20170000380A
Date Registered:
11/10/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Apellis Pharmaceuticals, Inc.
Address:
6400 Westwind Way Suite A, Crestwood, KY 40014, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/01/2020
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
11/10/2017 Request For Change 7
27/09/2017 Power Of Attorney 1
24/10/2017 Outgoing Correspondence 1
29/09/2017 Outgoing Correspondence 1